Alto Neuroscience, Inc.
ANRO
$27.04
$1.746.88%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.89M | 20.75M | 21.88M | 23.28M | 22.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.83M | 66.36M | 66.31M | 70.24M | 69.90M |
| Operating Income | -77.83M | -66.36M | -66.31M | -70.24M | -69.90M |
| Income Before Tax | -74.31M | -63.24M | -62.26M | -64.86M | -63.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.31 | -63.24 | -62.26 | -64.86 | -63.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.31M | -63.24M | -62.26M | -64.86M | -63.18M |
| EBIT | -77.83M | -66.36M | -66.31M | -70.24M | -69.90M |
| EBITDA | -77.15M | -65.70M | -65.63M | -69.61M | -69.32M |
| EPS Basic | -2.45 | -2.21 | -2.31 | -2.41 | -2.35 |
| Normalized Basic EPS | -1.53 | -1.37 | -1.43 | -1.49 | -1.45 |
| EPS Diluted | -2.45 | -2.21 | -2.31 | -2.41 | -2.35 |
| Normalized Diluted EPS | -1.53 | -1.37 | -1.43 | -1.49 | -1.45 |
| Average Basic Shares Outstanding | 121.25M | 115.41M | 108.00M | 107.85M | 107.70M |
| Average Diluted Shares Outstanding | 121.25M | 115.41M | 108.00M | 107.85M | 107.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |